MentionFox
Home › funding signals › Linnaeus Therapeutics, Inc.
Form D · on the record

Linnaeus Therapeutics — $3.73M Form D filing, November 2026

Before you sell to, join or invest in Linnaeus Therapeutics, Inc.

MentionFox check on Linnaeus Therapeutics, Inc.: only 1 source on file so far (checked 19 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/linnaeus-therapeutics-inc-form-d-000008

Check Linnaeus Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Linnaeus Therapeutics, Inc.?

Linnaeus Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-18.

Linnaeus Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 18, 2026. The filing reports $3.73M sold. Its industry group is Biotechnology. It names Patrick Mooney (Director), Chris Arendt (Director), Michael Poisel (Director) (SEC Form D, November 18, 2026).

Sell to companies like Linnaeus Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Linnaeus Therapeutics, Inc. raised on Nov 18. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

3 more Biotechnology raises in New Jersey within 90 days ↓

Selling to Linnaeus Therapeutics, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on Linnaeus Therapeutics, Inc. →

Linnaeus Therapeutics, Inc.

New Form D on file · 2026-11-18 · the record

$3.73M
raise on the record
D
filing
4
investors in
NEW JERSEY
based
Open the record →

What the record says

FilingForm D
Filed2026-11-18
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedHADDONFIELD, NEW JERSEY
CIK1752026
Accession0001752026-26-000008

Pitching, partnering or investing alongside them? See who really runs and owns Linnaeus Therapeutics, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Linnaeus Therapeutics, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in New Jersey, filed within 90 days of this one, largest first.

What do you want to do with Linnaeus Therapeutics, Inc.?

Get the full cited report on Linnaeus Therapeutics, Inc.

What the filing shows about Linnaeus Therapeutics, Inc.

  • 4 investors had already put money in when it filed.
  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Linnaeus Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Linnaeus Therapeutics, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Linnaeus Therapeutics, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Linnaeus Therapeutics, Inc.'s address as 30 Washington Avenue, Suite F, Haddonfield, NJ 08033.

What the filing says

  • Offered: $10,000,000. Sold: $3,734,103. Left to sell: $6,265,897. (filing)
  • Investors: 4 had already invested. (filing)
  • Date of first sale: November 16, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Linnaeus Therapeutics, Inc. See pricing

Is Linnaeus Therapeutics, Inc. a real, registered company?

Linnaeus Therapeutics, Inc. is a registered filer with the SEC (CIK 1752026) and has filed since 2023-01-26. 9 filings are on record, the latest on 2026-11-18.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Linnaeus Therapeutics, Inc.?

Linnaeus Therapeutics, Inc.'s Form D of 2026-11-18 names Patrick Mooney, Chris Arendt, Michael Poisel and 3 more as its officers, directors or promoters.

How much has Linnaeus Therapeutics, Inc. raised?

Its new offerings report $14.20M sold across 5 offerings, as its own filings state.

Filing history · 9 filings on this registrant
Form D · 2023-01-26 · $3.09MForm D · 2024-08-12 · $1.63MForm D/A, amended · 2024-12-26 · $5.82MForm D · 2025-08-22 · $1.27MForm D · 2026-02-27 · $4.47MForm D/A, amended · 2026-03-13 · $4.79MForm D/A, amended · 2026-03-31 · $4.89MForm D/A, amended · 2026-04-02 · $4.99MForm D · 2026-11-18 · $3.73M · this page 2023-01-26 2026-11-18

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $3.73M, filed week of Nov 16

Trailing twelve months. 758 filings in Biotechnology, totalled by week. The dot is this raise, $3.73M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Linnaeus Therapeutics, Inc.?

What the filing shows about Linnaeus Therapeutics, Inc.

  • 4 investors had already put money in when it filed.
  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Linnaeus Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Linnaeus Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Linnaeus Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Linnaeus Therapeutics, Inc.: Raised $3.73M, Form D filed 2026-11-18
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/linnaeus-therapeutics-inc-form-d-000008
Last updated 2026-11-19
Primary record: SEC filing 1 · SEC filing 2
Linnaeus Therapeutics raised $3.73M — SEC Form D filing, November 2026. MentionFox, 2026-11-19. https://mentionfox.com/funding/linnaeus-therapeutics-inc-form-d-000008